معرفی
Wenxue Li is an Associate Research Scientist in the Department of Pharmacology at Yale University's Yale School of Medicine. Their research focuses on proteomics, phosphoproteomics, and their applications in understanding cancer biology, cell signaling pathways, and drug resistance mechanisms. They have contributed to advancements in phosphoproteomic analysis, nanodisc technology for membrane protein extraction, and the development of targeted therapeutic approaches like PhosTACs. Dr. Li collaborates extensively with researchers in pharmacology, biochemistry, and systems biology to elucidate molecular mechanisms underlying diseases such as cancer and neurodegeneration.
Key research areas include the dynamic regulation of protein turnover, signaling pathways in CD8+ T cells, and aneuploidy's role in oncogenesis. Their work integrates cutting-edge proteomic techniques with computational methods to uncover novel therapeutic targets and biomarkers. Recent publications highlight studies on ERK signaling, mitotic regulation, and optogenetic tools for studying Akt1 signaling in endothelial cells.